APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Menopause Blood Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Menopause Blood Test Market Outlook and Growth Opportunities 2026

Report ID 17418710042 May 2026198 pages

Choose your research edition.

Industry ResearchMenopause Blood Test Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopause Blood Test Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Menopause Blood Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopause Blood Test Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopause Blood Test Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

The global Menopause Blood Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Menopause Blood Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Menopause Blood Test market include Thriva, MyHealthChecked, Forth, Labcorp OnDemand, Randox, Mina Health, OptimallyMe, Welzo and Quest, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Menopause Blood Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Menopause Blood Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Menopause Blood Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Menopause Blood Test market.

Menopause Blood Test Segment by Company

Thriva

MyHealthChecked

Forth

Labcorp OnDemand

Randox

Mina Health

OptimallyMe

Welzo

Quest

LifeCell

High Trees Clinics

Thorne HealthTech

Everlywell

ZRT Laboratory

Medichecks

Menopause Blood Test Segment by Type

Fingerstick Blood

Venous Blood

Menopause Blood Test Segment by Application

Premenopausal

Postmenopausal

Menopause Blood Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Menopause Blood Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Menopause Blood Test key companies, revenue, market share, and recent developments.

3. To split the Menopause Blood Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Menopause Blood Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Menopause Blood Test significant trends, drivers, influence factors in global and regions.

6. To analyze Menopause Blood Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopause Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Blood Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Menopause Blood Test industry.

Chapter 3: Detailed analysis of Menopause Blood Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Menopause Blood Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Menopause Blood Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Menopause Blood Test Industry Trends Table 2. Menopause Blood Test Industry Drivers Table 3. Menopause Blood Test Industry Opportunities and Challenges Table 4. Menopause Blood Test Industry Restraints Table 5. Global Menopause Blood Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Menopause Blood Test Revenue Share by Company (2021-2026) Table 7. Global Menopause Blood Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Menopause Blood Test Key Company Manufacturing Base & Headquarters Table 9. Global Menopause Blood Test Company, Product Type & Application Table 10. Global Menopause Blood Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Menopause Blood Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fingerstick Blood Table 15. Significant Companies of Venous Blood Table 16. Global Menopause Blood Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Menopause Blood Test Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Menopause Blood Test Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Menopause Blood Test Sales Value Share by Type (2021-2026) Table 20. Global Menopause Blood Test Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Premenopausal Table 22. Significant Companies of Postmenopausal Table 23. Global Menopause Blood Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Menopause Blood Test Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Menopause Blood Test Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Menopause Blood Test Sales Value Share by Application (2021-2026) Table 27. Global Menopause Blood Test Sales Value Share by Application (2027-2032) Table 28. Global Menopause Blood Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Menopause Blood Test Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Menopause Blood Test Sales Value Share by Region (2021-2026) Table 31. Global Menopause Blood Test Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Menopause Blood Test Sales Value Share by Region (2027-2032) Table 33. Global Menopause Blood Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Menopause Blood Test Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Menopause Blood Test Sales Value Market Share by Country (2021-2026) Table 36. Global Menopause Blood Test Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Menopause Blood Test Sales Value Market Share by Country (2027-2032) Table 38. Thriva Company Information Table 39. Thriva Business Overview Table 40. Thriva Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Thriva Menopause Blood Test Product Portfolio Table 42. Thriva Recent Development Table 43. MyHealthChecked Company Information Table 44. MyHealthChecked Business Overview Table 45. MyHealthChecked Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. MyHealthChecked Menopause Blood Test Product Portfolio Table 47. MyHealthChecked Recent Development Table 48. Forth Company Information Table 49. Forth Business Overview Table 50. Forth Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Forth Menopause Blood Test Product Portfolio Table 52. Forth Recent Development Table 53. Labcorp OnDemand Company Information Table 54. Labcorp OnDemand Business Overview Table 55. Labcorp OnDemand Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Labcorp OnDemand Menopause Blood Test Product Portfolio Table 57. Labcorp OnDemand Recent Development Table 58. Randox Company Information Table 59. Randox Business Overview Table 60. Randox Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Randox Menopause Blood Test Product Portfolio Table 62. Randox Recent Development Table 63. Mina Health Company Information Table 64. Mina Health Business Overview Table 65. Mina Health Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Mina Health Menopause Blood Test Product Portfolio Table 67. Mina Health Recent Development Table 68. OptimallyMe Company Information Table 69. OptimallyMe Business Overview Table 70. OptimallyMe Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. OptimallyMe Menopause Blood Test Product Portfolio Table 72. OptimallyMe Recent Development Table 73. Welzo Company Information Table 74. Welzo Business Overview Table 75. Welzo Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Welzo Menopause Blood Test Product Portfolio Table 77. Welzo Recent Development Table 78. Quest Company Information Table 79. Quest Business Overview Table 80. Quest Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Quest Menopause Blood Test Product Portfolio Table 82. Quest Recent Development Table 83. LifeCell Company Information Table 84. LifeCell Business Overview Table 85. LifeCell Menopause Blood Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. LifeCell Menopause Blood Test Product Portfolio Table 87. LifeCell Recent Development Table 88. High Trees Clinics Company Information Table 89. High Trees Clinics Business Overview Table 90. High Trees Clinics Menopause Blood Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. High Trees Clinics Menopause Blood Test Product Portfolio Table 92. High Trees Clinics Recent Development Table 93. Thorne HealthTech Company Information Table 94. Thorne HealthTech Business Overview Table 95. Thorne HealthTech Menopause Blood Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Thorne HealthTech Menopause Blood Test Product Portfolio Table 97. Thorne HealthTech Recent Development Table 98. Everlywell Company Information Table 99. Everlywell Business Overview Table 100. Everlywell Menopause Blood Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Everlywell Menopause Blood Test Product Portfolio Table 102. Everlywell Recent Development Table 103. ZRT Laboratory Company Information Table 104. ZRT Laboratory Business Overview Table 105. ZRT Laboratory Menopause Blood Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ZRT Laboratory Menopause Blood Test Product Portfolio Table 107. ZRT Laboratory Recent Development Table 108. Medichecks Company Information Table 109. Medichecks Business Overview Table 110. Medichecks Menopause Blood Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Medichecks Menopause Blood Test Product Portfolio Table 112. Medichecks Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Menopause Blood Test Product Image Figure 2. Global Menopause Blood Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Menopause Blood Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Menopause Blood Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fingerstick Blood Image Figure 8. Venous Blood Image Figure 9. Global Menopause Blood Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Menopause Blood Test Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Menopause Blood Test Sales Value Share by Type (2021-2032) Figure 12. Premenopausal Image Figure 13. Postmenopausal Image Figure 14. Global Menopause Blood Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Menopause Blood Test Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Menopause Blood Test Sales Value Share by Application (2021-2032) Figure 17. Global Menopause Blood Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Menopause Blood Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Menopause Blood Test Sales Value (2021-2032) & (US$ Million) Figure 20. North America Menopause Blood Test Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Menopause Blood Test Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Menopause Blood Test Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Menopause Blood Test Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Menopause Blood Test Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Menopause Blood Test Sales Value (2021-2032) & (US$ Million) Figure 26. South America Menopause Blood Test Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Menopause Blood Test Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Menopause Blood Test Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Menopause Blood Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Menopause Blood Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Menopause Blood Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Fingerstick Blood
  • Venous Blood
Applications
  • Premenopausal
  • Postmenopausal
Companies covered
  • Thriva
  • MyHealthChecked
  • Forth
  • Labcorp OnDemand
  • Randox
  • Mina Health
  • OptimallyMe
  • Welzo
  • Quest
  • LifeCell
  • High Trees Clinics
  • Thorne HealthTech
  • Everlywell
  • ZRT Laboratory
  • Medichecks

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Menopause Blood Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Menopause Blood Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Menopause Blood Test Market Dynamics
  1. 2.1 Menopause Blood Test Industry Trends
  2. 2.2 Menopause Blood Test Industry Drivers
  3. 2.3 Menopause Blood Test Industry Opportunities and Challenges
  4. 2.4 Menopause Blood Test Industry Restraints
3 Menopause Blood Test Market by Company
  1. 3.1 Global Menopause Blood Test Company Revenue Ranking in 2025
  2. 3.2 Global Menopause Blood Test Revenue by Company (2021-2026)
  3. 3.3 Global Menopause Blood Test Company Ranking (2024-2026)
  4. 3.4 Global Menopause Blood Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Menopause Blood Test Company Product Type and Application
  6. 3.6 Global Menopause Blood Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Menopause Blood Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Menopause Blood Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Menopause Blood Test Market by Type
  1. 4.1 Menopause Blood Test Type Introduction
  2. 4.1.1 Fingerstick Blood
  3. 4.1.2 Venous Blood
  4. 4.2 Global Menopause Blood Test Sales Value by Type
  5. 4.2.1 Global Menopause Blood Test Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Menopause Blood Test Sales Value by Type (2021-2032)
  7. 4.2.3 Global Menopause Blood Test Sales Value Share by Type (2021-2032)
5 Menopause Blood Test Market by Application
  1. 5.1 Menopause Blood Test Application Introduction
  2. 5.1.1 Premenopausal
  3. 5.1.2 Postmenopausal
  4. 5.2 Global Menopause Blood Test Sales Value by Application
  5. 5.2.1 Global Menopause Blood Test Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Menopause Blood Test Sales Value by Application (2021-2032)
  7. 5.2.3 Global Menopause Blood Test Sales Value Share by Application (2021-2032)
6 Menopause Blood Test Regional Value Analysis
  1. 6.1 Global Menopause Blood Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Menopause Blood Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Menopause Blood Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Menopause Blood Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Menopause Blood Test Sales Value (2021-2032)
  7. 6.3.2 North America Menopause Blood Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Menopause Blood Test Sales Value (2021-2032)
  10. 6.4.2 Europe Menopause Blood Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Menopause Blood Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Menopause Blood Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Menopause Blood Test Sales Value (2021-2032)
  16. 6.6.2 South America Menopause Blood Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Menopause Blood Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Menopause Blood Test Sales Value Share by Country, 2025 VS 2032
7 Menopause Blood Test Country-level Value Analysis
  1. 7.1 Global Menopause Blood Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Menopause Blood Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Menopause Blood Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Menopause Blood Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Menopause Blood Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Menopause Blood Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Menopause Blood Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Menopause Blood Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Menopause Blood Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Menopause Blood Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Menopause Blood Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Menopause Blood Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Menopause Blood Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Menopause Blood Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Menopause Blood Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Menopause Blood Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Menopause Blood Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Menopause Blood Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Menopause Blood Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Menopause Blood Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Menopause Blood Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Menopause Blood Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Menopause Blood Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Menopause Blood Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Menopause Blood Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Menopause Blood Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Menopause Blood Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Menopause Blood Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Menopause Blood Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Menopause Blood Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Menopause Blood Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Menopause Blood Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Menopause Blood Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Menopause Blood Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thriva
  2. 8.1.1 Thriva Company Information
  3. 8.1.2 Thriva Business Overview
  4. 8.1.3 Thriva Menopause Blood Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thriva Menopause Blood Test Product Portfolio
  6. 8.1.5 Thriva Recent Developments
  7. 8.2 MyHealthChecked
  8. 8.2.1 MyHealthChecked Company Information
  9. 8.2.2 MyHealthChecked Business Overview
  10. 8.2.3 MyHealthChecked Menopause Blood Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MyHealthChecked Menopause Blood Test Product Portfolio
  12. 8.2.5 MyHealthChecked Recent Developments
  13. 8.3 Forth
  14. 8.3.1 Forth Company Information
  15. 8.3.2 Forth Business Overview
  16. 8.3.3 Forth Menopause Blood Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Forth Menopause Blood Test Product Portfolio
  18. 8.3.5 Forth Recent Developments
  19. 8.4 Labcorp OnDemand
  20. 8.4.1 Labcorp OnDemand Company Information
  21. 8.4.2 Labcorp OnDemand Business Overview
  22. 8.4.3 Labcorp OnDemand Menopause Blood Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Labcorp OnDemand Menopause Blood Test Product Portfolio
  24. 8.4.5 Labcorp OnDemand Recent Developments
  25. 8.5 Randox
  26. 8.5.1 Randox Company Information
  27. 8.5.2 Randox Business Overview
  28. 8.5.3 Randox Menopause Blood Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Randox Menopause Blood Test Product Portfolio
  30. 8.5.5 Randox Recent Developments
  31. 8.6 Mina Health
  32. 8.6.1 Mina Health Company Information
  33. 8.6.2 Mina Health Business Overview
  34. 8.6.3 Mina Health Menopause Blood Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mina Health Menopause Blood Test Product Portfolio
  36. 8.6.5 Mina Health Recent Developments
  37. 8.7 OptimallyMe
  38. 8.7.1 OptimallyMe Company Information
  39. 8.7.2 OptimallyMe Business Overview
  40. 8.7.3 OptimallyMe Menopause Blood Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OptimallyMe Menopause Blood Test Product Portfolio
  42. 8.7.5 OptimallyMe Recent Developments
  43. 8.8 Welzo
  44. 8.8.1 Welzo Company Information
  45. 8.8.2 Welzo Business Overview
  46. 8.8.3 Welzo Menopause Blood Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Welzo Menopause Blood Test Product Portfolio
  48. 8.8.5 Welzo Recent Developments
  49. 8.9 Quest
  50. 8.9.1 Quest Company Information
  51. 8.9.2 Quest Business Overview
  52. 8.9.3 Quest Menopause Blood Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Quest Menopause Blood Test Product Portfolio
  54. 8.9.5 Quest Recent Developments
  55. 8.10 LifeCell
  56. 8.10.1 LifeCell Company Information
  57. 8.10.2 LifeCell Business Overview
  58. 8.10.3 LifeCell Menopause Blood Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LifeCell Menopause Blood Test Product Portfolio
  60. 8.10.5 LifeCell Recent Developments
  61. 8.11 High Trees Clinics
  62. 8.11.1 High Trees Clinics Company Information
  63. 8.11.2 High Trees Clinics Business Overview
  64. 8.11.3 High Trees Clinics Menopause Blood Test Revenue and Gross Margin (2021-2026)
  65. 8.11.4 High Trees Clinics Menopause Blood Test Product Portfolio
  66. 8.11.5 High Trees Clinics Recent Developments
  67. 8.12 Thorne HealthTech
  68. 8.12.1 Thorne HealthTech Company Information
  69. 8.12.2 Thorne HealthTech Business Overview
  70. 8.12.3 Thorne HealthTech Menopause Blood Test Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thorne HealthTech Menopause Blood Test Product Portfolio
  72. 8.12.5 Thorne HealthTech Recent Developments
  73. 8.13 Everlywell
  74. 8.13.1 Everlywell Company Information
  75. 8.13.2 Everlywell Business Overview
  76. 8.13.3 Everlywell Menopause Blood Test Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Everlywell Menopause Blood Test Product Portfolio
  78. 8.13.5 Everlywell Recent Developments
  79. 8.14 ZRT Laboratory
  80. 8.14.1 ZRT Laboratory Company Information
  81. 8.14.2 ZRT Laboratory Business Overview
  82. 8.14.3 ZRT Laboratory Menopause Blood Test Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ZRT Laboratory Menopause Blood Test Product Portfolio
  84. 8.14.5 ZRT Laboratory Recent Developments
  85. 8.15 Medichecks
  86. 8.15.1 Medichecks Company Information
  87. 8.15.2 Medichecks Business Overview
  88. 8.15.3 Medichecks Menopause Blood Test Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medichecks Menopause Blood Test Product Portfolio
  90. 8.15.5 Medichecks Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst